SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences soars on selling leasehold rights on surplus land to Maruti Suzuki

07 Jun 2013 Evaluate

RPG Life Sciences is currently trading at Rs. 68.80, up by 3.20 points or 4.88% from its previous closing of Rs. 65.60 on the BSE.

The scrip opened at Rs. 70.00 and has touched a high and low of Rs. 73.90 and Rs. 68.60 respectively. So far 93169 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 8 has touched a 52 week high of Rs. 94.80 on 04-Dec-2012 and a 52 week low of Rs. 48.10 on 13-Mar-2013.

Last one week high and low of the scrip stood at Rs. 77.90 and Rs. 64.75 respectively. The current market cap of the company is Rs. 118.64 crore.

The promoters holding in the company stood at 56.48% while Institutions and Non-Institutions held 2.42% and 41.10% respectively.

RPG Life Sciences has sold leasehold rights on its surplus land admeasuring 14,148.90 square meters, situated at TTC Industrial area, Village Pawane, Navi Mumbai to Maruti Suzuki India for the consideration of Rs 76.91 crore. The RPG Group company acquired land admeasuring 48,632 square meters on 95 years lease from Maharashtra Industrial Development Corporation (MIDC). Out of this, part of land admeasuring 14,148.90 square meters was surplus land.

The proceeds from the transaction will be utilized for reducing the debt of the company and investing in projects to drive future growth of the company.

RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space.

RPG Life Sciences Share Price

2025.85 126.05 (6.63%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×